Project Name：Vildagliptin
Registration Classification：3+6
Formulations and specifications ：Tablets: 50mg
Indications：This product is suitable for the treatment of type 2 diabetes : When metformin is already being used to the maximum tolerated dose as monotherapy still can not effectively control blood sugar, this product can be used in combination with metformin .
Original Research Company：Novartis Pharma Stein AG
Progress ：Pharmaceutical Research in progress
Category ：Antidiabetic drugs
